ABBOTT LABORATORIES (ABT) Options Risk Score

Run a full ABT options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.

Is it risky to sell options on ABBOTT LABORATORIES (ABT) right now?

ABBOTT LABORATORIES (ABT) currently scores 71 out of 100 for options catalyst risk (HIGH) over a 4-week expiry window. What pushes it there: 1 recent news item, 10 active legal filings, 2 recent SEC events and 39 clinical-trial catalysts, all landing inside the 4-week window. Anything at 70 or above counts as HIGH, meaning the premium on ABT is at least partly compensation for a scheduled event rather than pure time value. It says nothing about direction — only that something is on the calendar.

ABT shows an IV Rank of 59, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 32%. Read IV Rank alongside the catalyst score: it says how expensive ABT options are, while the score says whether that price is justified by a scheduled event.

ABT's next earnings date is 2026-10-21, outside the near-term options window; the stock has moved down 3.8% recently.

ABBOTT LABORATORIES (ABT) current implied volatility and IV Rank

ABT is trading at an IV Rank of 59 with implied volatility around 32%, alongside a TickerRisk options-risk score of 71/100. That's moderate — options are fairly priced versus the past year, so there's no strong volatility edge in either direction right now; trade the direction, not the vol.

IV Rank is an index, not a percentage — it says where ABT's implied volatility sits inside its own 1-year range. How to read IV Rank →

ABBOTT LABORATORIES (ABT) next earnings date — 2026-10-21

ABBOTT LABORATORIES (ABT) next reports earnings on 2026-10-21 — about 0 days away. That's outside the nearest options expiry window, so it isn't an immediate catalyst — but it's worth tracking, since implied volatility typically starts building one to two weeks ahead of the report. ABT's IV Rank is currently 59.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer